Adoptive immunotherapy with natural killer cells from peripheral blood CD34(+) stem cells to prevent hepatocellular carcinoma recurrence after curative hepatectomy: a study protocol for an open-label, single-arm phase I study

INTRODUCTION: Hepatocellular carcinoma (HCC) remains a major clinical problem as more than half of these cases recur after radical resection. Natural killer (NK) cells are at the forefront of the innate immune system and attack microcarcinomas and circulating tumour cells. The objective of this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohira, Masahiro, Kobayashi, Tsuyoshi, Tanaka, Yuka, Imaoka, Yuki, Sato, Koki, Imaoka, Koki, Nakano, Ryosuke, Doskali, Marlen, Piao, Jinlian, Nakamura, Mayuna, Yoshida, Tetsumi, Ichinohe, Tatsuo, Kawano, Reo, Yoshimura, Kenichi, Ueda, Keiko, Tamura, Natsuko, Hirata, Taizo, Imamura, Michio, Aikata, Hiroshi, Tanimine, Naoki, Kuroda, Shintaro, Tahara, Hiroyuki, Ide, Kentaro, Ohdan, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680173/
https://www.ncbi.nlm.nih.gov/pubmed/36410831
http://dx.doi.org/10.1136/bmjopen-2022-064526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680173/
https://www.ncbi.nlm.nih.gov/pubmed/36410831
http://dx.doi.org/10.1136/bmjopen-2022-064526

Ejemplares similares